Core D(Experimental Animals) will provide centralized facilities and technical expertise to conduct in vivo experiments using Ad vectors in rodents. The primary resource of the animal core is a technician who will assist the scientists of the projects in the design and execution of animal experiments. The technician will train project scientists, assist in surgical procedures and dissection, and coordinate with RARC staff in the compliance with regulatory requirements. The technician will also stock and maintain procedure rooms, keep inventory, log procedures and inspect animals daily. The core will be located within a 3,000 square foot animal facility occupy part of a new Gene Therapy Core Facility which includes the other cores of this program project. The animal facility was designed specifically to house and manipulate animals employed in gene therapy studies under BSL2 conditions. To maintain rodents free of intercurrent infection with adventitious pathogens, they will be housed in individually ventilated isolator caging systems. The facility contains four animal holding rooms, one of which is equipped with five Illinois cubicles. Experimental procedure rooms contain multiple work areas for manipulating rodent models and a surgical suite for surgical delivery of vectors, if necessary. Underlying the core functions are the support staff, facilities, and programs of Cornell University Medical College's Research Animal Resource Center (RARC) including RARC's Research Animal Diagnostic Laboratory (RADL), which will provide expertise in clinical and anatomic pathology. All biological materials introduced into rodents housed in the core will be evaluated by the RADL for contamination with adventitious viruses and mycoplasma. The health status of rodents housed in the ore will be continuously monitored for contamination with adventitious pathogens.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL051746-08
Application #
6445182
Study Section
Project Start
2001-04-01
Project End
2002-03-31
Budget Start
Budget End
Support Year
8
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Ryan, Dorothy M; Vincent, Thomas L; Salit, Jacqueline et al. (2014) Smoking dysregulates the human airway basal cell transcriptome at COPD risk locus 19q13.2. PLoS One 9:e88051
Dvorak, Anna; Tilley, Ann E; Shaykhiev, Renat et al. (2011) Do airway epithelium air-liquid cultures represent the in vivo airway epithelium transcriptome? Am J Respir Cell Mol Biol 44:465-73
Krause, Anja; Whu, Wen Zhu; Xu, Yaqin et al. (2011) Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF. Vaccine 29:2131-9
Limberis, Maria P; Bell, Christie L; Heath, Jack et al. (2010) Activation of transgene-specific T cells following lentivirus-mediated gene delivery to mouse lung. Mol Ther 18:143-50
Song, Yuhu; Lou, Howard H; Boyer, Julie L et al. (2009) Functional cystic fibrosis transmembrane conductance regulator expression in cystic fibrosis airway epithelial cells by AAV6.2-mediated segmental trans-splicing. Hum Gene Ther 20:267-81
Vandenberghe, L H; Breous, E; Nam, H-J et al. (2009) Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints. Gene Ther 16:1416-28
Fein, David E; Limberis, Maria P; Maloney, Sean F et al. (2009) Cationic lipid formulations alter the in vivo tropism of AAV2/9 vector in lung. Mol Ther 17:2078-87
Limberis, Maria P; Vandenberghe, Luk H; Zhang, Liqun et al. (2009) Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol Ther 17:294-301
Tertilt, Christine; Joh, Ju; Krause, Anja et al. (2009) Expression of B-cell activating factor enhances protective immunity of a vaccine against Pseudomonas aeruginosa. Infect Immun 77:3044-55
Limberis, M P; Bell, C L; Wilson, J M (2009) Identification of the murine firefly luciferase-specific CD8 T-cell epitopes. Gene Ther 16:441-7

Showing the most recent 10 out of 85 publications